摘要
背景:PPARs是由膳食脂质或其代谢物(主要是脂肪酸和类花生酸)激活的脂质传感器,它们在CNS生物学中发挥关键作用,因为脑具有非常高的脂质含量并具有较高的体内代谢能力。 方法:在代谢障碍之外的神经退行性疾病中,还观察到神经炎症,并且PPAR也与炎症过程密切相关。一些研究揭示了先天免疫反应与组织代谢之间的复杂关系。 结果:在大脑中,在病理状态下,发生代谢状态的改变,特别是涉及葡萄糖利用和生产,这种状况通常与代谢变化有关。 结论:考虑到PPARs在脑中的高表达,本综述将侧重于这些转录因子在CNS疾病中的作用。
关键词: 神经变性疾病,免疫系统,小胶质细胞,细胞因子,神经炎症,神经元
Current Alzheimer Research
Title:PPARs in Neurodegenerative and Neuroinflammatory Pathways
Volume: 15 Issue: 4
关键词: 神经变性疾病,免疫系统,小胶质细胞,细胞因子,神经炎症,神经元
摘要: Background: PPARs are lipid sensors activated by dietary lipids or their metabolites, mainly fatty acids and eicosanoids, that play critical roles in CNS biology, since brain has a very high lipid content and has the higher energetic metabolism in the body.
Methods: In neurodegenerative diseases in addition to metabolic impairment, also neuroinflammation is observed and PPARs are also closely linked to inflammatory processes. Several studies have revealed a complicated relationship between the innate immune response and tissue metabolism.
Results: In the brain, during pathological conditions, an alteration in metabolic status occurs, particularly involving glucose utilization and production, a condition which is generally related to metabolic changes.
Conclusion: Taking into account the high expression of PPARs in the brain, this review will focus on the role of these transcription factors in CNS diseases.
Export Options
About this article
Cite this article as:
PPARs in Neurodegenerative and Neuroinflammatory Pathways, Current Alzheimer Research 2018; 15 (4) . https://dx.doi.org/10.2174/1567205014666170517150037
DOI https://dx.doi.org/10.2174/1567205014666170517150037 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Challenges to Overcome in the Management of Type 2 Diabetes Mellitus and Associated Neurological Disorders
CNS & Neurological Disorders - Drug Targets Botulinum Toxin as a Neuro-Relearning Drug Tool in Motor Paralytic Disorders
Current Drug Therapy Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease
Current Alzheimer Research Implications of Parkinson’s Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Opioids in Neuropathic Pain
Current Pharmaceutical Design Characterization of Endogenous Neural Progenitor Cells after Experimental Ischemic Stroke
Current Neurovascular Research The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury
Current Stem Cell Research & Therapy Attenuating Effect of Portulaca oleracea Extract on Chronic Constriction Injury Induced Neuropathic Pain in Rats: An Evidence of Anti-oxidative and Anti-inflammatory Effects
CNS & Neurological Disorders - Drug Targets Increasing Expression of Heme Oxygenase-1 by Proteasome Inhibition Protects Astrocytes from Heme-mediated Oxidative Injury
Current Neurovascular Research The Role of Glial Cells in Drug Abuse
Current Drug Abuse Reviews The GABAergic System and the Gastrointestinal Physiopathology
Current Pharmaceutical Design Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Current Neuropharmacology The Blood-brain Barrier and the Outer Blood-retina Barrier
Medicinal Chemistry Reviews - Online (Discontinued) Human Urotensin II and Metabolic Syndrome
Vascular Disease Prevention (Discontinued) Investigational Selective Melatoninergic Ligands for Receptor Subtype MT2
Mini-Reviews in Medicinal Chemistry Blood-Brain Barrier Integrity and Glial Support: Mechanisms that can be Targeted for Novel Therapeutic Approaches in Stroke
Current Pharmaceutical Design Rationally Designed Multitarget Agents Against Inflammation and Pain
Current Medicinal Chemistry GABAB Receptors-Associated Proteins: Potential Drug Targets in Neurological Disorders?
Current Drug Targets Cell Elimination as a Strategy for Repair in Acute Spinal Cord Injury
Current Pharmaceutical Design